Gene therapy
During World Blindness Awareness Month, Opus Genetics, a clinical-stage biopharmaceutical company, was highlighted on Good Morning America for its pioneering work in developing gene therapies for inherited retinal diseases. The feature story centered around Lindsey Rambo, the second participant in Opus Genetics' ongoing Phase 1/2 trial of gene
Gene therapy
A recent study by researchers at Nantong University has shed light on the crucial role of vascular endothelial dysfunction in atherosclerosis-induced erectile dysfunction (AED). The research, published in the journal Translational Andrology and Urology, found that the shared pathogenic drivers of atherosclerosis and AED contribute to a bidirectional relationship, with
Gene therapy
Gene therapy for Severe Combined Immunodeficiency (SCID), a rare inherited immune disorder, has faced significant challenges, particularly for RAG-deficient SCID. However, a recent patent filing by Laura Garcia-Perez, Arjan C. Lankester, Karin Pike-Overzet, Frank J. T. Staal, and Marja C. J. A. Van Eggermond from the Academy Hospital Leiden (H.
Gene therapy
Researchers from the University of Science and Technology China have made a significant discovery in the field of gene therapy, revealing that neuronal pentraxin 1 (NPTX1) plays a key role in the development of post-stroke atherosclerosis by inducing endothelial cell senescence. This study, published in International Immunopharmacology, suggests that NPTX1
T cells
Virax Biolabs Group Limited, a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases, has successfully completed patient recruitment for its clinical study evaluating the performance of the ViraxImmune[TM] assay in detecting T cell dysfunction in Post-Acute Infection Syndromes (PAIS). The study, conducted
T cells
Researchers from the University of Colorado Anschutz Medical Campus have made a groundbreaking discovery in understanding the mechanisms behind type 1 diabetes. By studying the formation of hybrid insulin peptides (HIPs), they found that a single leucine-to-isoleucine substitution in insulin C-peptide can significantly disrupt HIP formation in NOD mouse islets.
T cells
Caribou Biosciences, a clinical-stage CRISPR genome-editing biopharmaceutical company, has announced encouraging clinical data from its phase 1 trial evaluating CB-011, an off-the-shelf anti-BCMA CAR-T cell therapy, in patients with relapsed or refractory multiple myeloma. The results highlight the potential of CB-011 as a best-in-class allogeneic CAR-T cell therapy for this
Mining industry
A devastating earthquake triggered the collapse of a mine waste facility in Chile 60 years ago, resulting in a massive disaster that destroyed a nearby settlement and caused loss of life. Despite the mine's continued operation, survivors and their families still live downstream of the expanded facility, carrying
Health care industry
The healthcare industry is undergoing a significant shift as nearly 90% of healthcare executives agree that their organizations must fundamentally transform operations over the next five years to remain sustainable and meet evolving patient and market demands. The fifth annual report by Chartis, a leading healthcare advisory firm, reveals that
Health care industry
The North East and North Cumbria Integrated Care Board (ICB) has launched a new online platform, the People's Hub, which enables patients, carers, and families to have a say in shaping healthcare services in their area. The hub is hosted on Boost, the NHS's learning website,
Health care industry
Healthcare systems are focusing on immediate priorities such as improving quality of care and cost containment, while deprioritizing strategies that have proven links to better outcomes and financial sustainability. A national survey by Arcadia Research Report reveals that healthcare leaders are struggling to balance short-term goals with long-term impact. The
Health care industry
The report "KOL Compensation Australia Cardiology" provides fair-market value (FMV) compensation rates for Australian Key Opinion Leaders (KOLs) in cardiology, offering a comprehensive guide to industry standards. Amidst growing scrutiny of payments made to physicians and thought leaders, companies have been adjusting their rates to align with industry
